Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of MTR mRNA | affects expression | 21346803
|
C030371 |
5,6,7,8-tetrahydrofolic acid |
5,6,7,8-tetrahydrofolic acid inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | decreases expression|decreases reaction | 16598758
|
C030371 |
5,6,7,8-tetrahydrofolic acid |
[Thymidine co-treated with Hypoxanthine co-treated with 5,6,7,8-tetrahydrofolic acid] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
C005984 |
5-methyltetrahydrofolate |
5-methyltetrahydrofolate binds to MTR protein | affects binding | 17477549
|
D012436 |
S-Adenosylmethionine |
S-Adenosylmethionine binds to MTR protein | affects binding | 17477549
|
D006710 |
Homocysteine |
Homocysteine binds to MTR protein | affects binding | 17477549
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MTR mRNA | affects expression | 16483693
|
D001562 |
Benzimidazoles |
Benzimidazoles results in decreased activity of MTR protein | decreases activity | 17222188
|
C015700 |
benzo-1,2,3-thiadiazole |
benzo-1,2,3-thiadiazole analog results in decreased activity of MTR protein | decreases activity | 17222188
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MTR mRNA | decreases expression | 20064835
|
D004317 |
Doxorubicin |
MTR mRNA results in decreased susceptibility to Doxorubicin | decreases response to substance | 16322897
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MTR mRNA | increases expression | 17606305
|
D005492 |
Folic Acid |
Folic Acid affects the expression of MTR mRNA | affects expression | 17311948
|
D019271 |
Hypoxanthine |
[Thymidine co-treated with Hypoxanthine co-treated with 5,6,7,8-tetrahydrofolic acid] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
D019271 |
Hypoxanthine |
[Thymidine co-treated with Hypoxanthine] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
D008727 |
Methotrexate |
5,6,7,8-tetrahydrofolic acid inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | decreases expression|decreases reaction | 16598758
|
D008727 |
Methotrexate |
Methotrexate results in decreased expression of MTR protein | decreases expression | 16598758
|
D008727 |
Methotrexate |
[Thymidine co-treated with Hypoxanthine co-treated with 5,6,7,8-tetrahydrofolic acid] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
D008727 |
Methotrexate |
[Thymidine co-treated with Hypoxanthine] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MTR mRNA | affects binding|increases activity|increases expression | 19710929
|
D013311 |
Streptozocin |
Streptozocin results in decreased activity of MTR protein | decreases activity | 16835399
|
D013936 |
Thymidine |
[Thymidine co-treated with Hypoxanthine co-treated with 5,6,7,8-tetrahydrofolic acid] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
D013936 |
Thymidine |
[Thymidine co-treated with Hypoxanthine] inhibits the reaction [Methotrexate results in decreased expression of MTR protein] | affects cotreatment|decreases expression|decreases reaction | 16598758
|
D014805 |
Vitamin B 12 |
Vitamin B 12 binds to MTR protein | affects binding | 17477549
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.21 | 12039119 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
4.29 | 17003819 16316344 16595132 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.08 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.00 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.00 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.00 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.89 | 6695378 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
6.89 | 16963246 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.44 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.50 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
5.20 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Vitamin B 12 |
5.20 | 17116317 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.03 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.42 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.64 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.09 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
5-methyltetrahydrofolate |
3.67 | 18461502 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
3.67 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
3.67 | 20468076 16297937 |
MESH:D001321 |
Autistic Disorder |
|
S-Adenosylmethionine |
3.67 | 19056591 16917939 |
MESH:D001321 |
Autistic Disorder |
|
Vitamin B 12 |
3.67 | 16297937 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.11 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.67 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.77 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17595805 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.05 | 18628466 16826403 16264153 16322301 16096432 17426702 18695136 15567936 15939500 15993339 18234424 11325840 15136595 17983394 19526202 15692762 15668708 16935488 15634643 17369602 15994142 16595493 18382427 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
2.05 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.05 | 16978400 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.60 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
12.60 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.11 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.11 | 17876044 18059187 16234567 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.14 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.65 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.65 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.50 | 15476868 16651473 16731534 17928571 15505089 17924179 16364871 15792986 16109756 16278810 17131338 17007740 17308081 17351982 17329180 18627295 16269455 16612575 17519947 17382496 16455267 16242529 17974986 15811867 16952015 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.93 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
3.92 | 16755160 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.74 | 6135515 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.63 | 11677210 16105132 17110522 17681005 17333356 16919318 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.63 | 19176532 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 21254359 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.96 | 21254359 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
3.55 | 21254359 8946559 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.90 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
2.90 | 17116713 17245555 16963246 17087956 16985020 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.74 | 16379339 |
MESH:D023903 |
Coronary Restenosis |
|
Vitamin B 12 |
6.21 | 16489563 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.65 | 12039119 9562676 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.98 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.20 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.08 | 20191521 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.69 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
4.44 | 18715473 15862027 12093613 19960420 15831366 12644472 17874149 18603373 12083368 16684804 19586609 12446591 16286809 19496084 11260395 2177838 17442507 6379147 1374869 7637645 11055810 19298542 15298345 8740154 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.62 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
5.16 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
5.16 | 19586609 19647726 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.69 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
4.63 | 19682444 19960420 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.38 | 17662242 |
MESH:D004314 |
Down Syndrome |
marker/mechanism |
|
| |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.99 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.99 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.64 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.44 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.15 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.82 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
7.82 | 17301261 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.13 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.00 | 16530937 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
13.27 | 16504073 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
13.27 | 16504073 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.41 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.41 | 20131406 19236843 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.55 | 19069698 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
5.06 | 17171786 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
11.71 | 16504073 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
11.71 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.32 | 17150277 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.11 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.50 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
16.00 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
16.00 | 16524890 17286298 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
16.00 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin B 12 |
16.00 | 17124548 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
8.01 | 16244372 16707910 18006777 16244371 16879835 16144979 17875725 12587719 14766674 16495754 16330681 17888722 18674790 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
8.01 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.96 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.96 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.86 | 15692506 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.96 | 16221962 19772884 18467677 19176532 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.46 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.37 | 15147373 18501091 17606976 |
MESH:D006712 |
Homocystinuria |
|
5-methyltetrahydrofolate |
6.79 | 17413090 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
15.66 | 16395265 16433478 16865747 16755160 16397167 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
15.66 | 17369066 18234410 17292331 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Vitamin B 12 |
15.66 | 16397167 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.77 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
MESH:D007248 |
Infertility, Male |
marker/mechanism |
|
| 16861746 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.46 | 17937319 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.60 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.58 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
6.58 | 12093613 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.11 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
2.94 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.06 | 9562676 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.13 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.68 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
5.12 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.12 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
S-Adenosylmethionine |
5.12 | 15983038 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin B 12 |
5.12 | 18239293 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
3.03 | 16877991 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.27 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.27 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.27 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.97 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.97 | 16842330 17085340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.99 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.50 | 20135361 18520028 18569708 18816296 20869020 20464547 6695378 17053015 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.50 | 6189445 17418594 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
6.25 | 17718048 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Vitamin B 12 |
6.25 | 17718048 |
MESH:D008223 |
Lymphoma |
marker/mechanism |
|
| 16799656 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.81 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
7.81 | 17352296 |
MESH:D008224 |
Lymphoma, Follicular |
marker/mechanism |
|
| 16410450 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.75 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.53 | 15621674 |
MESH:D044342 |
Malnutrition |
marker/mechanism |
|
| 16709328 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.00 | 15458769 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.66 | 16832597 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.28 | 16827129 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
5.50 | 16602021 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.04 | 17638057 |
OMIM:250940 |
METHYLCOBALAMIN DEFICIENCY, cblG TYPE |
marker/mechanism |
|
| |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.46 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.15 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
12.40 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
12.40 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
13.55 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
13.55 | 17412321 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
13.55 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Vitamin B 12 |
13.55 | 17412321 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.91 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.83 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.93 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.75 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.75 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.73 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.96 | 15640375 16889571 |
MESH:D009436 |
Neural Tube Defects |
|
5-methyltetrahydrofolate |
8.33 | 17413090 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
8.33 | 17438019 |
OMIM:601634 |
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE |
marker/mechanism |
|
| |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.24 | 15555623 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
4.46 | 16322990 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.39 | 16049721 |
OMIM:119530 |
OROFACIAL CLEFT 1 |
marker/mechanism |
|
| |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.08 | 15930896 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
3.56 | 16275827 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.13 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.13 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.30 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.30 | 16868541 16729912 15749863 15897917 18437689 16888761 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.42 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
17.09 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
17.09 | 15728788 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
17.09 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.36 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.95 | 17203757 16767912 17710206 15625365 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.20 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.75 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
4.24 | 16641680 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
4.24 | 16641680 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.50 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.24 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.74 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.74 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.53 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.91 | 16709447 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
13.65 | 16361298 |
MESH:D013118 |
Spinal Cord Diseases |
|
Vitamin B 12 |
13.65 | 16361298 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.67 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
2.67 | 17171786 |
MESH:D020521 |
Stroke |
|
Folic Acid |
9.53 | 16517955 |
MESH:D020521 |
Stroke |
|
Vitamin B 12 |
9.53 | 16517955 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.99 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.33 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.23 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.23 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.23 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.28 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.26 | 14692618 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.18 | 17334414 17638931 17678736 16364871 |